Lithium Controlled-Release and Extended-Release Tablets and Synalar Ointment
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Synalar Ointment and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: fluocinolone topical
Brand name: Capex, Flurosyn, Synalar, Synalar Ointment, Derma-Smoothe/FS
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Synalar Regular
- Lithium Controlled-Release and Extended-Release Tablets-Synalar Solution
- Lithium Controlled-Release and Extended-Release Tablets-Synalgos-DC
- Lithium Controlled-Release and Extended-Release Tablets-Synalgos-DC Oral
- Lithium Controlled-Release and Extended-Release Tablets-Synamol
- Lithium Controlled-Release and Extended-Release Tablets-Synapryn FusePaq
- Synalar Ointment-Lithium ER
- Synalar Ointment-Lithium Oral Solution
- Synalar Ointment-Lithium Salts
- Synalar Ointment-Lithium Syrup and Oral Solution
- Synalar Ointment-Lithobid
- Synalar Ointment-Lithostat